Link Immunotherapeutics Analysis: $51M Raised
What is Link Immunotherapeutics?
Groundbreaking therapies through rigorous science
HQ Country
Seattle, United States
Employees
1-10
Founded
2020
HQ State/Province
Washington
Funding Category
Acquired
HQ Full Address
1616 Eastlake Ave E, Seattle, Washington 98102, United States
Product Features & Capabilities
- Therapeutics targeting validated cancer markers
- Novel target combinations for improved efficacy
Other Considerations
Founded in 2020; Based in Seattle, Washington; Supported by an experienced Board of Directors
